Literature DB >> 16809210

Brain injury following neuroleptic malignant syndrome: case report and review of the literature.

Anna Labuda1, Nora Cullen.   

Abstract

OBJECTIVE: To report a case of brain injury following neuroleptic malignant syndrome (NMS) and review the literature for similar documented cases. CASE REPORT: A 30-year old woman presented to the ER with psychotic features and was treated with several anti-psychotics. Subsequently, she developed neurological symptoms and was diagnosed with neuroleptic malignant syndrome. Following a prolonged course in an acute care facility, she was admitted to a rehabilitation ward, where cognitive and physical examinations revealed significant findings. These included marked dysarthria, difficulties comprehending commands, attention problems, as well as abnormalities in her muscle tone, power, reflexes, gait, co-ordination and sensory function.
CONCLUSION: Literature reviews reveal few documented cases of brain injury following neuroleptic malignant syndrome. A further exploration of the effects of NMS on the brain is warranted to elicit whether cerebellar damage is indeed common following neuroleptic malignant syndrome. Such research could eventually lead to therapeutic interventions aimed at preventing permanent brain injury in persons with NMS.

Entities:  

Mesh:

Year:  2006        PMID: 16809210     DOI: 10.1080/02699050600663022

Source DB:  PubMed          Journal:  Brain Inj        ISSN: 0269-9052            Impact factor:   2.311


  3 in total

1.  Getting hot and bothered….

Authors:  Edward Walter; Mike Carraretto
Journal:  J Intensive Care Soc       Date:  2015-07-23

2.  Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting?

Authors:  Deepali Dixit; Pranabh Shrestha; Marc Adelman
Journal:  BMJ Case Rep       Date:  2013-07-12

Review 3.  The neurological and cognitive consequences of hyperthermia.

Authors:  Edward James Walter; Mike Carraretto
Journal:  Crit Care       Date:  2016-07-14       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.